Current partner codePEPTIDESDE
PeptideStat
Menu

Vendors

Compare pricesVendor directoryVendor reviewsDiscount codesLab tests & COAs

Research

ResearchDatabaseClinical trials

Tools

All calculatorsReconstitutionAccumulationUnit converterPeptide chemistry
Research onlyGrowth hormoneSubcutaneousEvidence 3/5

CJC-1295

Also known as: DAC:GRF

Long-acting growth-hormone-releasing hormone analog. The DAC variant binds serum albumin to extend half-life and sustain GH/IGF-1 elevation.

Browse research guidesView clinical trialsRecheck source availability
Illustrative subcutaneous database profile for CJC-1295
Illustrative profileSubcutaneous
Database profileResearch only
CJC-1295Growth hormone
Drug class
GHRH analog (with or without DAC)
Primary targets
GHRH receptor
Dose reference
1–2 mg weekly (DAC, research)
Half-life
~6–8 days (DAC)
Developer / origin
ConjuChem (original)
Reference year
2005
Evidence score
3/5 - Limited human pharmacology
Evidence 3/5

Limited human pharmacology

CJC-1295 has human pharmacology data showing prolonged GH/IGF-1 stimulation, but it is not approved and lacks long-term outcome evidence.

Limited human pharmacology or small clinical evidence.

Evidence basis

  • Human GH/IGF-1 pharmacology
  • Long-acting GHRH analog data
  • No approved indication

How to read this entry

Dose references and half-life values are pulled from trial protocols, labels, reviews, or published summaries where available. They are context for research and comparison, not a personal dosing recommendation.

Status matters: approved drugs have regulated indications; investigational compounds are still being studied; research-only peptides do not have established human dosing, safety, or efficacy for consumer use.

CJC-1295 guides

Read the matching guide or adjacent research pages for more context.

CJC-1295: DAC vs No-DAC, Evidence and Safety RisksCJC-1295 has human GH and IGF-1 pharmacology data, but no approved indication and no robust outcome trials for anti-aging, recovery or body composition claims.Banned Peptides in Sport: WADA Rules for BPC-157, CJC-1295 and SecretagoguesA peptide can be popular in recovery forums and still be prohibited in sport. WADA risk depends on approval status, mechanism, growth-factor effects and the current Prohibited List.Growth Hormone Peptide Side Effects: GH, IGF-1, Glucose and Safety LimitsGH-axis peptides can raise growth hormone or IGF-1 biomarkers, but side effects, glucose effects, product quality and evidence gaps differ sharply by compound.Sermorelin: What the GHRH Analog Does — and What It Doesn'tSermorelin is a GHRH (growth-hormone-releasing hormone) analog — not a GLP-1, despite being searched alongside them. What it does to growth hormone, and where it stands legally.

CJC-1295 calculator shortcuts

Open peptide calculators with editable CJC-1295 example values already filled in.

CJC-1295 reconstitution calculatorPrefills a 5 mg vial, 2 mL BAC water and editable dose fields.Open prefilled toolCJC-1295 accumulation calculatorPrefills 168 hour half-life and 168 hour interval examples.Open prefilled toolCJC-1295 unit converterPrefills 1 mg with a 5 mg vial example.Open prefilled tool

Peptide calculators

Use calculators for concentration, unit conversion and repeated-dose accumulation math.

Peptide reconstitution calculatorCalculate concentration, draw volume and syringe units from vial strength and BAC water.Open toolPeptide accumulation calculatorModel repeated dosing schedules with half-life, interval, peak and trough estimates.Open toolPeptide unit converterConvert mg, mcg, optional IU and syringe units from one reconstituted vial setup.Open toolPeptide chemistry calculatorAnalyze sequence length, molecular weight, composition, charge, hydropathy and notation.Open tool

Compare with related peptides

Stay inside the same research category and compare mechanism, status and evidence quality.

Ipamorelin

NNC 26-0161

3/5
Growth hormoneResearch only

Selectively stimulates pituitary growth hormone release without significant cortisol or prolactin elevation seen with older GHRPs.

DetailsGuide
5/5
Growth hormoneApproved

Stabilized GHRH analog. Approved for reduction of excess visceral abdominal fat in HIV-associated lipodystrophy.

Details

IGF-1 LR3

Long R3 IGF-1

2/5
Growth hormoneResearch only

A modified IGF-1 that binds IGF binding proteins far more weakly than native IGF-1, leaving it free to act as a potent, long-acting agonist at the IGF-1 receptor.

DetailsGuide

IGF-1 DES

DES(1-3) IGF-1

2/5
Growth hormoneResearch only

Removal of the N-terminal tripeptide sharply lowers IGF-binding-protein affinity while preserving IGF-1 receptor binding, leaving more free peptide to activate IGF-1R.

DetailsGuide

Category hub

Open the category page for the full comparison table and FAQ.

Growth Hormone Peptides

Compare growth hormone peptides including ipamorelin, CJC-1295 and tesamorelin by GH-axis mechanism, approval status, half-life and evidence score.

Read this first

PeptideStat is educational, not medical advice. Many compounds we cover are investigational or research-only and are not approved for human use. Partner links may earn us a commission without changing your price or our editorial conclusions.

Full disclosure →